10 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18355637 | COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN CANCERS | GIBBS, TERRA C | 1635 | Non-Final OA | Jul 20, 2023 |
| 18355280 | METHODS FOR INDUCING ADIPOSE TISSUE REMODELING USING RNAI THERAPEUTICS | HUDSON, AMY ROSE | 1636 | Non-Final OA | Jul 19, 2023 |
| 18126145 | NUCLEOSIDE CONTAINING siRNAS FOR TREATING VIRAL DISEASES | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Mar 24, 2023 |
| 18179410 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PCSK9 | GIBBS, TERRA C | 1635 | Non-Final OA | Mar 07, 2023 |
| 18111335 | METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-Protein | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Feb 17, 2023 |
| 18111309 | METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST TGFB1 AND COX2 | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Feb 17, 2023 |
| 17935022 | NANOPARTICLE PHARMACEUTICAL COMPOSITIONS WITH REDUCED NANOPARTICLE SIZE AND IMPROVED POLYDISPERSITY INDEX | GREENE, IVAN A | 1619 | Final Rejection | Sep 23, 2022 |
| 17935014 | NANOPARTICLE FORMULATIONS FORMED FROM HISTIDINE-LYSINE COPOLYMERS | COHEN, MICHAEL P | 1612 | Non-Final OA | Sep 23, 2022 |
| 17951842 | METHODS FOR PREPARING NANOPARTICLE COMPOSITIONS CONTAINING HISTIDINE-LYSINE COPOLYMERS | YU, DELPHINUS DOU YI | 1636 | Non-Final OA | Sep 23, 2022 |
| 17713037 | Tumor-Targeting Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics | REYNOLDS, FRED H | 1658 | Final Rejection | Apr 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial